Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2020 | Features of COVID-19 infection in hematology patients

William Wood • 14 Dec 2020
ASH 2020
General

William Wood, MD, MPH, University of North Carolina, Chapel Hill, NC, discusses an analysis of COVID-19 infection features and outcomes in patients with hematological malignancies, using the ASH Research Collaborative COVID-19 Registry for Hematology. Blood cancer patients are often older and have comorbid illness, as well as immune dysfunction and immunosuppression due to their cancer treatment. To understand the risks associated with COVID-19 infection in these patients, data was collected from patients with current or previous hematological disease and a COVID-19 diagnosis. The data showed that these patients experienced significant morbidity and mortality from COVID-19 infection, particularly individuals with a poor cancer prognosis. Data accumulation to expand the registry is ongoing. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals